Literature DB >> 17622003

Vertical ridge augmentation with autogenous bone grafts: resorbable barriers supported by ostheosynthesis plates versus titanium-reinforced barriers. A preliminary report of a blinded, randomized controlled clinical trial.

Mauro Merli1, Massimo Migani, Marco Esposito.   

Abstract

PURPOSE: To compare the efficacy and complications of 2 different techniques for vertical bone augmentation at implant placement: particulated autogenous bone grafts covered either by resorbable collagen barriers supported by osteosynthesis plates (test) or by nonresorbable titanium-reinforced e-polytetrafluoroethylene (e-PTFE) barrier (control).
MATERIALS AND METHODS: Twenty-two partially edentulous patients requiring vertical bone augmentation were randomly allocated to 2 treatment groups of 11 patients each. Early implant failures, the amount of vertically regenerated bone measured intrasurgically, and biologic complications were recorded by an independent assessor blinded to the group allocation. The implant site requiring the most vertical bone regeneration was selected in each patient for the bone gain assessment. Patients were followed from implant insertion with simultaneous augmentation procedure to insertion of the provisional restoration. Paired and independent t tests and Fisher exact tests were conducted to compare means and proportions at the .05 level of significance.
RESULTS: No patient dropped out or was excluded. Both procedures obtained significant bone gain and achieved the desired results, 2.2 mm (SD 1.5; P < .001) on average for resorbable barriers and 2.5 mm (SD 1.1) for nonresorbable barriers (P < .001). There was no statistically significant difference in bone gain between the 2 procedures (P = .58). Complications occurred in 40% of the patients. There was no difference in occurrence of complications between the procedures (P > .99). Three major complications occurred, 2 in the resorbable group and 1 in the nonresorbable group, which determined the complete failure of the augmentation procedure.
CONCLUSIONS: Both techniques were effective in augmenting bone; however, both were associated with complications. Clinicians and patients must carefully weigh risks and benefits when considering the use of vertical guided bone regeneration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17622003

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Implants        ISSN: 0882-2786            Impact factor:   2.804


  6 in total

Review 1.  Interventions for replacing missing teeth: horizontal and vertical bone augmentation techniques for dental implant treatment.

Authors:  Marco Esposito; Maria Gabriella Grusovin; Pietro Felice; Georgios Karatzopoulos; Helen V Worthington; Paul Coulthard
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

2.  Soft and hard tissue management in implant therapy-part I: surgical concepts.

Authors:  Antonio D'Addona; Marjan Ghassemian; Luca Raffaelli; Paolo Francesco Manicone
Journal:  Int J Biomater       Date:  2012-07-08

3.  Evaluation of complication rates and vertical bone gain after guided bone regeneration with non-resorbable membranes versus titanium meshes and resorbable membranes. A randomized clinical trial.

Authors:  Alessandro Cucchi; Elisabetta Vignudelli; Aldo Napolitano; Claudio Marchetti; Giuseppe Corinaldesi
Journal:  Clin Implant Dent Relat Res       Date:  2017-07-26       Impact factor: 3.932

4.  Ridge augmentation in implant dentistry.

Authors:  Young-Kyun Kim; Jeong-Kui Ku
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2020-06-30

Review 5.  Short Dental Implants (≤7mm) Versus Longer Implants in Augmented Bone Area: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Priscila N Uehara; Victor Haruo Matsubara; Fernando Igai; Newton Sesma; Marcio K Mukai; Mauricio G Araujo
Journal:  Open Dent J       Date:  2018-04-30

6.  Vertical-guided bone regeneration with a titanium-reinforced d-PTFE membrane utilizing a novel split-thickness flap design: a prospective case series.

Authors:  Peter Windisch; Kristof Orban; Giovanni E Salvi; Anton Sculean; Balint Molnar
Journal:  Clin Oral Investig       Date:  2020-10-10       Impact factor: 3.573

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.